Skip to Content

Author: Thomas DeFelice

Dilworth IP Partner Appointed to CURE’s Board of Directors

Dr. Anthony Sabatelli, Partner and Chair of Dilworth IP’s Biotech and Pharmaceutical IP practice group, has been appointed to serve on CURE’s Board of Directors. CURE (Connecticut United for Research Excellence) serves as the bioscience cluster for the state, and is a diverse community of small and large life and healthcare sciences companies, ranging in scope from therapeutics, to healthcare technology, to medical devices. Universities, government agencies, scientists, educators, mentors, students, entrepreneurs, business experts, service providers and investors further form the breadth of the network. Regarding his appointment, Dr. Sabatelli said that “I am honored to serve CURE in this capacity because it is an important advocate for the state’s bioscience community.”

Innovation: from Discovery to Application – Dilworth IP Attorneys to Present at ACS Fall Meeting in Boston

Dr. Anthony Sabatelli and Dr. Jonathan Schuchardt, both Partners at Dilworth IP, will be presenting at the 250th American Chemical Society National Meeting and Exposition in Boston this Thursday, August 20th. The theme of this year’s meeting is Innovation: from Discovery to Application and both presentations will be part of the ACS’s Chemistry and the Law (CHAL) Division’s slate of talks.

Jessica Miles is the Latest Addition to the Dilworth IP Team

Dilworth IP’s Biotech and Pharmaceutical Practice Group has been joined by Jessica Miles, a Technology Specialist from Yale University’s Office of Cooperative Research (OCR). Ms. Miles is currently a Ph.D. candidate in Microbiology at Yale where her research has focused on identifying genetic mediators of interactions between the microbiome and infectious bacteria. She is also well-versed in biochemistry, molecular biology, and cell biology, having had over 10 years of research experience in five different academic laboratories. Jessica’s work at OCR involved a variety of technology areas including miRNA therapy, regenerative medicine, and immunotherapy. There, she evaluated early stage research and reviewed prior art to advance intellectual property with commercial potential. She also identified biotechnology and pharmaceutical companies for licensing opportunities and composed marketing material to promote technology licensing and research sponsorship.

Dilworth IP Sponsoring the CT Booth at BIO 2015

Michael Dilworth and Dr. Anthony Sabatelli of Dilworth IP will be attending the 2015 BIO National Convention in Philadelphia (BIO 2015) June 15th-19th. They will be joined by several other organizations and businesses from Connecticut’s life science community showcasing the state’s leadership in the biosciences. The Firm is one of several sponsors of the Connecticut Booth along with Yale University, the University of Connecticut, The Jackson Laboratory, the Town of Branford, CT, and CURE (CT United for Research Excellence).

Dr. Alpha-Cobb to Present at UConn Health’s Career Development Workshop Series

Cambria Alpha-Cobb, Ph.D., Technology Specialist at Dilworth IP, is presenting at a Career Development Workshop series at UConn Health this Thursday May 28, 2015, at 1:30 pm. The title of the presentation is How to stay close to science when you get pulled away from the bench: An introduction to a career in IP law.

The workshop series is designed to expose graduate students and postdoctoral scholars to various career opportunities in the life sciences. Dr. Alpha-Cobb will present on her career path in IP law, emphasizing the skill sets required at various stages of her career, including past, current and future positions!